Direkt zum Inhalt
Merck

ZRB2249

Sigma-Aldrich

Anti-Hexokinase-2 Antibody, clone 1F3 ZooMAb® Rabbit Monoclonal

enhanced validation
greener alternative

recombinant, expressed in HEK 293 cells

Synonym(e):

EC:2.7.1.1, HK II, Hexokinase type II, Hexokinase-B, Muscle form hexokinase

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
12352203

Biologische Quelle

rabbit

Qualitätsniveau

Rekombinant

expressed in HEK 293 cells

Konjugat

unconjugated

Antikörperform

purified antibody

Antikörper-Produkttyp

primary antibodies

Klon

1F3, recombinant monoclonal

Beschreibung

1F3 Clone

Produktlinie

ZooMAb® learn more

Form

lyophilized

Mol-Gew.

calculated mol wt 102.38 kDa
observed mol wt ~110 kDa

Aufgereinigt durch

using Protein A

Speziesreaktivität

mouse, human

Speziesreaktivität (Voraussage durch Homologie)

monkey

Verpackung

antibody small pack of 25 μL

Grünere Alternativprodukt-Eigenschaften

Waste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

Erweiterte Validierung

recombinant expression
Learn more about Antibody Enhanced Validation

Methode(n)

affinity binding assay: suitable
flow cytometry: suitable
immunohistochemistry: suitable
western blot: suitable

Isotyp

IgG

Epitopsequenz

N-terminal half

Protein-ID-Hinterlegungsnummer

UniProt-Hinterlegungsnummer

Grünere Alternativprodukt-Kategorie

Versandbedingung

ambient

Lagertemp.

2-8°C

Angaben zum Gen

human ... HK2(3099)

Allgemeine Beschreibung

We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry. This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
ZooMAb® antibodies represent an entirely new generation of recombinant monoclonal antibodies. Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb® antibodies are reliably available and ready to ship when you need them.

Spezifität

Clone 1F3 is a ZooMAb® rabbit recombinant monoclonal antibody that specifically detects Hexokinase -2. It targets an epitope within 22 amino acids from the N-terminal half.

Immunogen

KLH-conjugated linear peptide corresponding to 22 amino acids from the N-terminal half of human Hexokinase-2.

Anwendung

Quality Control Testing

Evaluated by Western Blotting in HeLa cell lysate.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected Hexokinase-2 in HeLa cell lysate.

Tested Applications

Western Blotting Analysis: A 1:1,000 dilution of a representative lot detected Hexokinase-2 in HCT116 and RAW264.7 cell lysates.

Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution of a representative lot detected Hexokinase-2 in human skeletal muscle tissue sections.

Affinity Binding Assay: A representative lot of this antibody bound Hexokinase-2 peptide with a KD of 2.2 x 10-6 in an affinity binding assay.

Flow Cytometry Analysis: 0.1 µg of a representative lot detected Hexokinase-2 in one million HeLa cells.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

Zielbeschreibung

Hexokinase-2 (UniProt: P52789; also known as EC:2.7.1.1, Hexokinase type II, HK II, Hexokinase-B, Muscle form hexokinase) is encoded by the HK2 gene (Gene ID: 3099) in human. Hexokinase-2 is a monomeric enzyme that is predominantly expressed in insulin-responsive tissues. It catalyzes the phosphorylation of glucose to produce glucose-6-phosphate, the initial step in glycolysis. It plays a key role in maintaining the integrity of the outer mitochondrial membrane by preventing the release of apoptogenic molecules from the intermembrane space and subsequent apoptosis. It is synthesized with a mitochondrial binding peptide (aa 1-16) and its N-and C-terminal halves contain a hexokinase domain, both of which display catalytic activity. Hexokinase-2 activity is elevated in tumor cells, which is crucial for the Warburg effect and for supporting the highly glycolytic nature of cancer cells.  The elevated amount of hexokinase-2 binds both the ATP and the incoming glucose to produce large amounts of glucose-6-phosphate that supports cell proliferation. In contrast to normal brain and low-grade glioma, which express hexokinase-1, glioblastoma multiforme has elevated levels of hexokinase-2 that correlates with worse overall survival rates. This ZooMAb® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Wolf, A., et al. (2011). J. Exp. Med. 208(2); 313-326; Chiara, F., et al. (2008). PLoS One. 3(3); e1852; Mathupala,SP., et al. (2006). Oncogene. 25(34); 4777-4786).

Physikalische Form

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.

Rekonstituierung

300 µg/mL after reconstitution at 25 µL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Lagerung und Haltbarkeit

Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.

Sonstige Hinweise

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Rechtliche Hinweise

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Haftungsausschluss

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Sie haben nicht das passende Produkt gefunden?  

Probieren Sie unser Produkt-Auswahlhilfe. aus.

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 1

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.